Inspire Medical Systems (INSP) Total Non-Current Liabilities (2017 - 2026)

Inspire Medical Systems (INSP) reported Total Non-Current Liabilities of $119.0 million for Q1 2026, up 25.29% on a YoY basis from $95.0 million in Q1 2025, and down 5.62% sequentially from $126.1 million in Q4 2025.

Inspire Medical Systems (INSP) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends

Inspire Medical Systems (INSP) has 10 years of Total Non-Current Liabilities data on file, last reported at $119.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Non-Current Liabilities rose 25.29% year-over-year to $119.0 million; the trailing twelve-month figure through Mar 2026 stood at $119.0 million (up 25.29% YoY), and the FY2025 full-year result was $126.1 million, up 6.34% from the prior year.
  • Total Non-Current Liabilities eased to $119.0 million in Q1 2026, from $126.1 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $141.1 million in Q3 2025 to a low of $57.2 million in Q3 2022.
  • A 5-year average of $95.3 million and a median of $95.2 million in 2023 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities slipped 2.22% in 2022 and jumped 66.46% in 2023, its largest moves.
  • Tracing INSP's Total Non-Current Liabilities over 5 years: stood at $68.7 million in 2022, then soared by 49.81% to $103.0 million in 2023, then rose by 15.14% to $118.5 million in 2024, then climbed by 6.34% to $126.1 million in 2025, then fell by 5.62% to $119.0 million in 2026.
  • Business Quant data shows INSP's Total Non-Current Liabilities at $119.0 million in Q1 2026, $126.1 million in Q4 2025, and $141.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 184.26 Bn 176.96 Bn 6.27 Bn -
2 Stryker 128.82 Bn 125.94 Bn 3.81 Bn 20.94 Bn
3 Medtronic 108.86 Bn 99.64 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 68.54 Bn 67.09 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 47.53 Bn 43.86 Bn 1.29 Bn 2.64 Bn
6 GE HealthCare Technologies 28.45 Bn 26.17 Bn 1.98 Bn 24.21 Bn
7 Dexcom 28.43 Bn 27.31 Bn 750.30 Mn 3.53 Bn
8 Smith & Nephew 26.96 Bn 26.39 Bn - 3.57 Bn
9 Koninklijke Philips 25.53 Bn 22.41 Bn 2.07 Bn 9.85 Bn
10 Inspire Medical Systems 1.46 Bn 1.18 Bn 176.91 Mn 118.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 118.97 Mn
Dec 31, 2025 126.05 Mn
Sep 30, 2025 141.15 Mn
Jun 30, 2025 124.27 Mn
Mar 31, 2025 94.96 Mn
Dec 31, 2024 118.54 Mn
Sep 30, 2024 99.48 Mn
Jun 30, 2024 90.17 Mn
Mar 31, 2024 96.67 Mn
Dec 31, 2023 102.95 Mn
Sep 30, 2023 95.17 Mn
Jun 30, 2023 88.74 Mn
Mar 31, 2023 67.05 Mn
Dec 31, 2022 68.72 Mn
Sep 30, 2022 57.17 Mn
Jun 30, 2022 64.87 Mn
Mar 31, 2022 64.52 Mn
Dec 31, 2021 65.90 Mn
Sep 30, 2021 58.47 Mn
Jun 30, 2021 52.18 Mn